Evidence map›Paper›PMID 42207865›Full record

ArticleCancer research2026

GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma.

Sathya Sriramareddy, Navya Siddarajappa, Jun Sung Park, Thanh Nguyen, Jeffim N Kuznetsoff, Stefan Kurtenbach, James J Dollar, David J Adams, Jonathan D Licht, Zelia M Correa and 3 more

Abstract read
In one paragraph

Article in Cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Sathya SriramareddyThe Department of Tumor Microenvironment and Metastasis, The Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0000-0001-9189-3956
Navya SiddarajappaThe Department of Tumor Microenvironment and Metastasis, The Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0009-0000-6717-6404
Jun Sung ParkMedical Research Council Translational Immune Discovery Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-7149-6769
Thanh NguyenDepartment of Biostatistics, University of Utah, Salt Lake City, Utah.ORCID 0009-0008-5975-978X
Jeffim N KuznetsoffDepartment of Ophthalmology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0002-6197-2642
Stefan KurtenbachDepartment of Ophthalmology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0002-7445-596X
James J DollarDepartment of Ophthalmology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0003-2416-4272
David J AdamsWellcome Sanger Institute , Hinxton, United Kingdom.ORCID 0000-0001-9490-0306
Jonathan D LichtUniversity of Florida Health Sciences Center, Gainesville, Florida.ORCID 0000-0002-3942-1369
Zelia M CorreaDepartment of Ophthalmology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0003-2946-3757
Y Ann ChenDepartment of Biostatistics, University of Utah, Salt Lake City, Utah.ORCID 0000-0003-1468-3490
J William HarbourDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-1104-9809
Keiran S M SmalleyThe Department of Tumor Microenvironment and Metastasis, The Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0000-0003-1089-9307

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
University of Florida Health Cancer Center Support GrantP30CA247796 · NCI · UNIVERSITY OF FLORIDA · PI DIETMAR W SIEMANN · 2023 to 2026
$10.9M
Stem Cell, Organoid and Cell Phenotyping ModuleP30EY030413 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI W MATTHEW PETROLL · 2019 to 2026
$5.9M
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasisR01CA256193 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI HARBOUR, JAMES WILLIAM, LICHT, JONATHAN D. · 2021 to 2025
$3.2M
Cancer Prevention and Research Institute of Texas (CPRIT) RR220010National Eye Institute (NEI) P30 EY030413National Institutes of Health (NIH) P30 CA076292National Institutes of Health (NIH) P30 CA142543National Institutes of Health (NIH) P30 CA247796National Institutes of Health (NIH) R01CA256193NCI NIH HHS P30 CA076292NCI NIH HHS P30 CA142543NCI NIH HHS P30 CA247796NCI NIH HHS R01 CA256193NEI NIH HHS P30 EY030413Research to Prevent Blindness (RPB)State of FloridaState of Florida 381.915
6 · The paper itself

Abstract

Uveal melanoma is an aggressive tumor type that frequently results in fatal liver metastasis. A better understanding of the interactions between uveal melanoma and host cells in the tumor microenvironment that promote liver metastasis could lead to the development of therapeutic strategies. In this study, we used single-cell RNA-sequencing analysis of uveal melanoma-hepatic stellate cell (HSC) cocultures to explore the mechanisms by which uveal melanoma cells metastasize to the liver. HSCs enriched for uveal melanoma cell states that expressed genes implicated in cell survival, metabolic reprogramming, and growth differentiation factor 15 (GDF15)-mediated angiogenesis. The TGFβ family member GDF15 was associated with a metastatic uveal melanoma phenotype. Silencing of BAP1 in uveal melanoma cells led to increased GDF15 expression and accumulation of H3K27ac marks at the GDF15 promoter. Treatment of HSCs with GDF15 led to increased expression of extracellular matrix (ECM) proteins, inflammatory cytokines, and angiogenic factors, including IL8. Both exogenous GDF15 and IL8, as well as conditioned media from uveal melanoma-HSC cocultures, increased endothelial cell network formation in vitro, an effect that was blocked by anti-GDF15 antibodies. In multiple models of metastatic uveal melanoma, silencing of GDF15 inhibited the outgrowth of metastatic lesions, associated with reduced deposition of ECM and recruitment of endothelial cells. Together, these findings reveal that uveal melanoma liver metastasis development is dependent on GDF15-mediated remodeling of the liver microenvironment, which leads to an angiogenic response and matrix deposition that supports tumor growth. SIGNIFICANCE: GDF15 functions as a growth factor that helps drive the development of liver metastases in uveal melanoma by contributing to angiogenesis and matrix deposition, allowing for metastatic outgrowth.

Indexed as

Growth Differentiation Factor 15Liver NeoplasmsMelanomaTumor MicroenvironmentUveal NeoplasmsAnimalsCell Line, TumorCoculture TechniquesGene Expression Regulation, NeoplasticHepatic Stellate CellsHumansMiceNeovascularization, PathologicUveal MelanomaGDF15 protein, humanGrowth Differentiation Factor 15

Identifiers

PMID42207865
PMCPMC13343499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.